ERBB2 and neoplasm: Similarly, in Her2-positive gastric cancer [82], organoids revealed that the anti-PD-1/Her2 bispecific antibody IBI315 could induce pyroptosis and activate T cells, creating a positive feedback loop for tumor cell killing.